Clinical Trials Logo

Progressive Keratoconus clinical trials

View clinical trials related to Progressive Keratoconus.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06450470 Not yet recruiting - Clinical trials for Progressive Keratoconus

Use of a Freeze-dried Amniotic Membrane Post Crosslinking in Subjects With Progressive Keratoconus

Start date: July 2024
Phase: Phase 3
Study type: Interventional

Crosslinking is a therapeutic technique used to increase the rigidity of the cornea in order to slow or stop progression of keratoconus. The main complication of the treatment of keratoconus by crosslinking is postoperative pain due to the removal of the corneal epithelium. Currently, the management of pain is done through the administration of artificial tears and paracetamol. The amniotic membrane is a biological tissue used in ophthalmology to treat injuries of the surface of the eye. It has healing and analgesic properties. The objective of this multicenter randomized study is to evaluate the benefit of placing an amniotic membrane on the eye post-crosslinking to reduce pain and promote corneal healing.

NCT ID: NCT00925327 Not yet recruiting - Clinical trials for Progressive Keratoconus

Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking for Compassionate Treatment in Pediatric Patients With Progressive Keratoconus

CXL
Start date: n/a
Phase: Phase 2
Study type: Interventional

This is a compassionate treatment protocol for the use of the UV-X system for corneal collagen cross-linking (CXL) in eyes with progressive keratoconus in patients who have conditions that limit their capacity to comply with the cross-linking treatment procedures required by ongoing clinical trials.